|
|
You are searching for "CFAMM00378501" in compound. Total 1 results found.
Click on CFAM IDs and names to search or view in CFAM, click on external IDs to view the entity in its source database.
CFAM Mol ID | CFAMM00378501 |
Family | CFFBM7253 Neutrophil collagenase and Matrix metalloproteinase-9 inhibitor (2S,3R,6S)-10-acetyl-2-N-hydroxy-6-N,12-dimethyl-4-oxo-3-(3-phenylpropyl)-1-oxa-5,10-diazacyclotridecane-2,6-dicarboxamide family |
Superfamily | CFSAD807 20S proteasome Inhibitor Carfilzomib Superfamily |
Class | CFCAD608 Class 608 |
External ID | CHEMBL32310 |
External Source | CHEMBL |
PubChem CID |
10371161 |
Functional Category |
Bioactive |
Molecule Name |
(2S,3R,6S)-10-(benzenesulfonyl)-2-N-hydroxy-6-N-methyl-4-oxo-3-(3-phenylpropyl)-1-oxa-5,10-diazacyclotetradecane-2,6-dicarboxamide |
IUPAC Name |
(2S,3R,6S)-10-(benzenesulfonyl)-2-N-hydroxy-6-N-methyl-4-oxo-3-(3-phenylpropyl)-1-oxa-5,10-diazacyclotetradecane-2,6-dicarboxamide |
Synonyms |
CHEBI:147264 |
InChi |
InChI=1S/C29H40N4O7S/c1-30-28(35)25-18-11-20-33(41(38,39)23-15-6-3-7-16-23)19-8-9-21-40-26(29(36)32-37)24(27(34)31-25)17-10-14-22-12-4-2-5-13-22/h2-7,12-13,15-16,24-26,37H,8-11,14,17-21H2,1H3,(H,30,35)(H,31,34)(H,32,36)/t24-,25+,26+/m1/s1 |
InChiKey |
KXPIKWNUKVNKRA-ZNZIZOMTSA-N |
Formula | C29H40N4O7S |
Molecular Weight | 588.72 |
Cross Link | CHEMBL32310 |
Structure |
|
Statistics of CFAM Database |
CFAM currently contains 490,279 molecules in 87,136 families, 34,880 superfamilies and 11,643 classes. |
How to cite our database |
C. Zhang, L. Tao, C. Qin, P. Zhang, S.Y. Chen, X. Zeng, F. Xu, Z. Chen, S.Y. Yang and Y.Z. CFam: A Chemical Families Database Based on Iterative Selection of Functional Seeds and Seed-Directed Compound Clustering.
Nucl. Acids Res. 43 (D1): D558-D565 (2015) (First published online: November 20, 2014).
|
Last update by |
2014.08.29
|
48686 visits since 2014 .........
Dr.
Chen Yuzong
Deputy
Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore
All rights reserved.
|